• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

鼻咽癌的 TNM 分期系统比较及新分期系统的建议。

Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system.

机构信息

Department of Radiation Oncology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, No. 651 Dongfeng Road East, Guangzhou 510060, Guangdong, China.

出版信息

Br J Cancer. 2013 Dec 10;109(12):2987-97. doi: 10.1038/bjc.2013.659. Epub 2013 Oct 22.

DOI:10.1038/bjc.2013.659
PMID:24149175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3859943/
Abstract

BACKGROUND

There are few systematic evaluations regarding the sixth and seventh editions of the UICC/AJCC TNM Staging System (TNM6th, TNM7th) and Chinese 2008 Staging System (TNMc2008) for nasopharyngeal carcinoma (NPC).

METHODS

We classified 2333 patients into intensity-modulated radiotherapy (IMRT) cohort (n=941) and conventional radiotherapy (CRT) cohort (n=1392). Tumour staging defined by TNM6th, TNM7th and TNMc2008 was compared based on Akaike information criterion (AIC) and Harrell's concordance index (c-index).

RESULTS

For T-classification, TNM6th (AIC=2585.367; c-index=0.6390385) had superior prognostic value to TNM7th (AIC=2593.242; c-index=0.6226889) and TNMc2008 (AIC=2593.998; c-index=0.6237146) in the IMRT cohort, whereas TNMc2008 was superior (AIC=5999.054; c-index=0.623547) in the CRT cohort. For N-classification, TNMc2008 had the highest prognostic value in both cohorts (AIC=2577.726, c-index=0.6297874; AIC=5956.339, c-index=0.6533576). Similar results were obtained when patients were stratified by chemotherapy types, age and gender. Using staging models in the IMRT cohort, we failed to identify better stage migrations than TNM6th T-classification and TNMc2008 N-classification. We therefore proposed to combine these categories; resultantly, stage groups of the proposed staging system showed superior prognostic value over TNM6th, TNM7th and TNMc2008.

CONCLUSION

TNM6th T-classification and TNMc2008 N-classification have superior prognostic value in the IMRT era. By combining them with slight modifications, TNM criteria can be unified and its prognostic value be improved.

摘要

背景

针对鼻咽癌,UICC/AJCC TNM 分期系统(TNM6th、TNM7th)和中国 2008 分期系统(TNMc2008)的第六版和第七版系统评价较少。

方法

我们将 2333 例患者分为调强放疗(IMRT)队列(n=941)和常规放疗(CRT)队列(n=1392)。根据 Akaike 信息准则(AIC)和 Harrell 一致性指数(c-index)比较基于 TNM6th、TNM7th 和 TNMc2008 的肿瘤分期。

结果

对于 T 分期,TNM6th(AIC=2585.367;c-index=0.6390385)在 IMRT 队列中的预后价值优于 TNM7th(AIC=2593.242;c-index=0.6226889)和 TNMc2008(AIC=2593.998;c-index=0.6237146),而在 CRT 队列中,TNMc2008(AIC=5999.054;c-index=0.623547)则具有优势。对于 N 分期,TNMc2008 在两个队列中均具有最高的预后价值(AIC=2577.726,c-index=0.6297874;AIC=5956.339,c-index=0.6533576)。当按化疗类型、年龄和性别对患者进行分层时,也得到了类似的结果。在 IMRT 队列中使用分期模型,我们未能发现优于 TNM6th T 分期和 TNMc2008 N 分期的更好的分期迁移。因此,我们建议将这些类别结合起来;结果表明,所提出的分期系统的分期组优于 TNM6th、TNM7th 和 TNMc2008。

结论

在调强放疗时代,TNM6th T 分期和 TNMc2008 N 分期具有更高的预后价值。通过对其进行轻微修改并将它们结合起来,可以统一 TNM 标准并提高其预后价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/3859943/2193da18ea89/bjc2013659f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/3859943/2193da18ea89/bjc2013659f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cab6/3859943/2193da18ea89/bjc2013659f1.jpg

相似文献

1
Comparison of TNM staging systems for nasopharyngeal carcinoma, and proposal of a new staging system.鼻咽癌的 TNM 分期系统比较及新分期系统的建议。
Br J Cancer. 2013 Dec 10;109(12):2987-97. doi: 10.1038/bjc.2013.659. Epub 2013 Oct 22.
2
Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial.非中国人人群中 AJCC/UICC 分期系统第 7 版与第 8 版与治疗前血浆 EBV DNA 水平联合用于鼻咽癌的比较:一项前瞻性随机试验的二次分析。
Jpn J Clin Oncol. 2019 Dec 27;49(12):1100-1113. doi: 10.1093/jjco/hyz109.
3
Validation of the 8th Edition of the UICC/AJCC Staging System for Nasopharyngeal Carcinoma From Endemic Areas in the Intensity-Modulated Radiotherapy Era.调强放疗时代来自鼻咽癌高发地区的第 8 版 UICC/AJCC 分期系统的验证。
J Natl Compr Canc Netw. 2017 Jul;15(7):913-919. doi: 10.6004/jnccn.2017.0121.
4
Validation and suggestion of eighth T classifications of the UICC/AJCC staging system for nasopharyngeal carcinoma patients: a retrospective analysis.UICC/AJCC鼻咽癌患者分期系统第八版T分类的验证与建议:一项回顾性分析
Jpn J Clin Oncol. 2018 Oct 1;48(10):927-933. doi: 10.1093/jjco/hyy109.
5
A comparison between the sixth and seventh editions of the UICC/AJCC staging system for nasopharyngeal carcinoma in a Chinese cohort.中国队列中 UICC/AJCC 鼻咽癌分期系统第六版与第七版的比较。
PLoS One. 2014 Dec 23;9(12):e116261. doi: 10.1371/journal.pone.0116261. eCollection 2014.
6
Validation of the 8th edition of AJCC/UICC staging system for nasopharyngeal carcinoma: Results from a non-endemic cohort with 10-year follow-up.第八版 AJCC/UICC 鼻咽癌分期系统的验证:来自具有 10 年随访的非流行地区队列的结果。
Oral Oncol. 2019 Nov;98:141-146. doi: 10.1016/j.oraloncology.2019.09.029. Epub 2019 Oct 4.
7
Comparison of the seventh and eighth editions of the UICC/AJCC staging system for nasopharyngeal carcinoma: analysis of 1317 patients treated with intensity-modulated radiotherapy at two centers.比较 UICC/AJCC 第七版和第八版鼻咽癌分期系统:两个中心 1317 例调强放疗患者的分析。
BMC Cancer. 2018 May 29;18(1):606. doi: 10.1186/s12885-018-4419-1.
8
Optimal colorectal cancer staging criteria in TNM classification.最优结直肠癌 TNM 分期标准。
J Clin Oncol. 2012 May 1;30(13):1519-26. doi: 10.1200/JCO.2011.39.4692. Epub 2012 Mar 19.
9
Nasopharyngeal carcinoma in a non-endemic country-Validation of the new NPC staging system.非鼻咽癌高发国家的鼻咽癌——新 NPC 分期系统的验证。
Acta Otorrinolaringol Esp (Engl Ed). 2023 Jan-Feb;74(1):39-49. doi: 10.1016/j.otoeng.2022.04.001.
10
Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.调强放射治疗时代AJCC/UICC鼻咽癌分期系统第8版提案
Cancer. 2016 Feb 15;122(4):546-58. doi: 10.1002/cncr.29795. Epub 2015 Nov 20.

引用本文的文献

1
Is the gemcitabin-cisplatin combination the optimal induction chemotherapy for non-Asian patients with nasopharyngeal carcinoma (NPC)? Insights from a cohort in northeastern Morocco.吉西他滨联合顺铂方案是否是北非非亚洲鼻咽癌(NPC)患者的最佳诱导化疗方案?来自摩洛哥东北部队列研究的见解。
Ecancermedicalscience. 2025 Jan 22;19:1829. doi: 10.3332/ecancer.2025.1829. eCollection 2025.
2
An interpretable machine learning model assists in predicting induction chemotherapy response and survival for locoregionally advanced nasopharyngeal carcinoma using MRI: a multicenter study.一种可解释的机器学习模型助力利用磁共振成像预测局部晚期鼻咽癌的诱导化疗反应和生存率:一项多中心研究
Eur Radiol. 2025 Feb 10. doi: 10.1007/s00330-025-11396-5.
3

本文引用的文献

1
Significant efficacies of neoadjuvant and adjuvant chemotherapy for nasopharyngeal carcinoma by meta-analysis of published literature-based randomized, controlled trials.基于文献的随机对照试验的荟萃分析显示新辅助化疗和辅助化疗对鼻咽癌的显著疗效。
Ann Oncol. 2013 Aug;24(8):2136-46. doi: 10.1093/annonc/mdt146. Epub 2013 Apr 23.
2
A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma.中国2008年版与美国癌症联合委员会(AJCC)第7版鼻咽癌分期系统的比较。
Am J Clin Oncol. 2015 Apr;38(2):189-96. doi: 10.1097/COC.0b013e31828f5c96.
3
Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy.
A Distinct Anti-EBV DNase Profile in Patients with Undifferentiated Nasopharyngeal Carcinoma Compared to Classical Antigens.
与经典抗原相比,未分化鼻咽癌患者具有独特的抗 EBV DNase 谱。
Viruses. 2023 Oct 26;15(11):2158. doi: 10.3390/v15112158.
4
Prognostic value of EBV DNA and platelet-to-lymphocyte ratio in patients with non-metastatic nasopharyngeal carcinoma: a retrospective study.EBV DNA 和血小板与淋巴细胞比值对非转移性鼻咽癌患者的预后价值:一项回顾性研究。
BMC Cancer. 2023 Jul 18;23(1):673. doi: 10.1186/s12885-023-11117-5.
5
Predicting prognosis of nasopharyngeal carcinoma based on deep learning: peritumoral region should be valued.基于深度学习预测鼻咽癌预后:应重视肿瘤周围区域。
Cancer Imaging. 2023 Feb 9;23(1):14. doi: 10.1186/s40644-023-00530-5.
6
Silencing of lncRNA MIR31HG promotes nasopharyngeal carcinoma cell proliferation and inhibits apoptosis through suppressing the PI3K/AKT signaling pathway.长链非编码 RNA MIR31HG 的沉默通过抑制 PI3K/AKT 信号通路促进鼻咽癌细胞增殖并抑制细胞凋亡。
J Clin Lab Anal. 2022 Dec;36(12):e24720. doi: 10.1002/jcla.24720. Epub 2022 Nov 8.
7
Selection and validation of chemotherapy beneficiaries among elderly nasopharyngeal carcinoma (NPC) patients treated with intensity-modulated radiation therapy (IMRT): a large real-world study.选择和验证接受调强放射治疗的老年鼻咽癌(NPC)患者中的化疗受益人群:一项大型真实世界研究。
Radiat Oncol. 2022 Aug 8;17(1):138. doi: 10.1186/s13014-022-02095-2.
8
A novel prognostic model predicts overall survival in patients with nasopharyngeal carcinoma based on clinical features and blood biomarkers.一种基于临床特征和血液生物标志物的新型预后模型可预测鼻咽癌患者的总生存期。
Cancer Med. 2021 Jun;10(11):3511-3523. doi: 10.1002/cam4.3839. Epub 2021 May 11.
9
Comparison of Induction Chemotherapy Plus Concurrent Chemoradiotherapy and Concurrent Chemoradiotherapy Alone in Locally Advanced Nasopharyngeal Carcinoma.局部晚期鼻咽癌诱导化疗联合同期放化疗与单纯同期放化疗的比较。
Technol Cancer Res Treat. 2021 Jan-Dec;20:1533033821990017. doi: 10.1177/1533033821990017.
10
Effect of Induction Chemotherapy in Nasopharyngeal Carcinoma: An Updated Meta-Analysis.诱导化疗在鼻咽癌中的作用:一项更新的荟萃分析。
Front Oncol. 2021 Jan 8;10:591205. doi: 10.3389/fonc.2020.591205. eCollection 2020.
采用国际共识指南的淋巴结分期系统预测了接受调强放疗的来自鼻咽癌高发区的患者的淋巴结状况。
Int J Radiat Oncol Biol Phys. 2013 Jun 1;86(2):249-56. doi: 10.1016/j.ijrobp.2012.09.003. Epub 2012 Nov 29.
4
Prognostic value and differences of the sixth and seventh editions of the UICC/AJCC staging systems in nasopharyngeal carcinoma.UICC/AJCC 分期系统第六版和第七版在鼻咽癌中的预后价值及差异。
J Cancer Res Clin Oncol. 2013 Feb;139(2):307-14. doi: 10.1007/s00432-012-1333-9. Epub 2012 Oct 16.
5
A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma.一项前瞻性、随机对照研究比较了调强放疗与常规二维放疗治疗鼻咽癌的疗效和毒性。
Radiother Oncol. 2012 Sep;104(3):286-93. doi: 10.1016/j.radonc.2012.08.013. Epub 2012 Sep 17.
6
The strength/weakness of the AJCC/UICC staging system (7th edition) for nasopharyngeal cancer and suggestions for future improvement.AJCC/UICC 分期系统(第 7 版)在鼻咽癌中的优势/劣势及未来改进建议。
Oral Oncol. 2012 Oct;48(10):1007-1013. doi: 10.1016/j.oraloncology.2012.03.022. Epub 2012 Apr 22.
7
Prognostic value of subclassification using MRI in the t4 classification nasopharyngeal carcinoma intensity-modulated radiotherapy treatment.MRI 用于 t4 分类鼻咽癌调强放疗治疗的亚分类的预后价值。
Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):196-202. doi: 10.1016/j.ijrobp.2011.11.021. Epub 2012 Jan 31.
8
The seventh edition of the UICC/AJCC staging system for nasopharyngeal carcinoma is prognostically useful for patients treated with intensity-modulated radiotherapy from an endemic area in China.国际抗癌联盟/美国癌症联合委员会第七版鼻咽癌分期系统对来自中国高发地区行调强放疗的患者具有预后价值。
Radiother Oncol. 2012 Sep;104(3):331-7. doi: 10.1016/j.radonc.2011.10.009. Epub 2011 Nov 19.
9
The prevalence and prevention of nasopharyngeal carcinoma in China.中国鼻咽癌的患病率与预防
Chin J Cancer. 2011 Feb;30(2):114-9. doi: 10.5732/cjc.010.10377.
10
Magnetic resonance imaging staging of nasopharyngeal carcinoma in the head and neck.头颈部鼻咽癌的磁共振成像分期
World J Radiol. 2010 May 28;2(5):159-65. doi: 10.4329/wjr.v2.i5.159.